Hamasaki, Yuko
Yamaguchi, Tetsuo
Takahashi, Yusuke
Hashimoto, Junya
Muramatsu, Masaki
Kawamura, Takeshi
Sakai, Ken
Shishido, Seiichiro
Tazaki, Miyako
Article History
Received: 4 September 2017
Accepted: 18 June 2018
First Online: 6 July 2018
Compliance with ethical standards
:
: Yuko Hamasaki belongs to an endowed department sponsored by Asahi Kasei Pharma Corporation, Novartis Pharma K.K., Chugai Pharmaceutical Co., and Astellas Pharma. Ken Sakai received annual consultant fees from JMS Co. Ltd. The other authors have no potential conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by a central ethics board at Toho University Omori Medical Center, the principal investigator’s institution (approval number: 24-124).
: Informed consent was obtained from all individual participants included in the study.